Preoperative antithrombin III supplementation before elective cardiac surgery with cardiopulmonary bypass

Phase 2, randomised, open-label trial of antithrombin III in Antithrombin deficiency (ATD) (2 arms), sponsored by Grifols. Primary endpoints: Average antithrombin III level at ICU admission and Proportion with antithrombin III level at least 58% at ICU admission. Started Mar 2009; status: completed.